NASDAQ:HCAT Health Catalyst (HCAT) Stock Price, News & Analysis $1.74 -0.04 (-1.98%) As of 12:18 PM Eastern This is a fair market value price provided by Massive. Learn more. Add Compare Share Share Stock Analysis Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsFinancialsInsider TradesNews and TrendsOptions ChainOwnershipSEC FilingsShort Interest About Health Catalyst Stock (NASDAQ:HCAT) View Price History Chart DataSkip Price History Chart 1 Day 5 Days 30 Days 90 Days 1 Year Advanced 1 Day 1 Day 5 Days 30 Days 90 Days 1 Year Advanced Show volume Show extended hours Get Health Catalyst alerts:Sign Up Key Stats Today's Range$1.71▼$1.8150-Day Range$1.53▼$2.3952-Week Range$0.96▼$3.62Volume191,386 shsAverage Volume984,479 shsMarket Capitalization$130.57 millionP/E RatioN/ADividend YieldN/APrice Target$2.15Consensus RatingHold Company Overview Health Catalyst, Inc. provides data and analytics technology and services for healthcare organizations. Its solutions are designed to help hospitals, health systems and other providers organize clinical, operational and financial data, identify opportunities for improvement, and support more informed decisions. The company’s offerings include its Health Catalyst Data Operating System, which integrates and manages healthcare data from multiple sources, along with analytics applications, artificial intelligence and machine-learning capabilities, and tools for population health, quality improvement, cost management and operational performance. Health Catalyst also provides implementation, consulting and ongoing support services to help customers apply analytics to clinical and business initiatives. Founded in 2008, Health Catalyst primarily serves healthcare organizations in the United States. Dan Burton serves as the company’s chief executive officer, and Health Catalyst’s common stock trades on the Nasdaq under the symbol HCAT.AI Generated. May Contain Errors. Read More Health Catalyst Stock Analysis - MarketRank™See Top-Rated MarketRank™ Stocks69th Percentile Overall ScoreHCAT MarketRank™: Health Catalyst scored higher than 69% of companies evaluated by MarketBeat, and ranked 241st out of 881 stocks in the healthcare sector. Scores are calculated by averaging available category scores, with extra weight given to analysis and valuation. Analyst's Opinion3.5 / 5Analyst RatingHold Consensus RatingHealth Catalyst has received a consensus rating of Hold. The company's average rating score is 2.11, and is based on no strong buy ratings, 2 buy ratings, 6 hold ratings, and 1 sell rating.Upside PotentialHealth Catalyst has a consensus price target of $2.15, representing about 21.1% upside from its current price of $1.78.Amount of Analyst CoverageHealth Catalyst has only been the subject of 4 research reports in the past 90 days.Read more about Health Catalyst's stock forecast and price target. Earnings and Valuation0.6 / 5Proj. Earnings GrowthDecreasing Earnings GrowthEarnings for Health Catalyst are expected to decrease in the coming year, from ($0.18) to ($0.19) per share.Price to Earnings Ratio vs. the MarketThe P/E ratio of Health Catalyst is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Earnings Ratio vs. SectorThe P/E ratio of Health Catalyst is -0.48, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.Price to Book Value per Share RatioHealth Catalyst has a P/B Ratio of 0.51. P/B Ratios below 1 indicate that a company could be undervalued with respect to its assets and liabilities.Read more about Health Catalyst's valuation and earnings. Short Interest2.0 / 5Short Interest LevelBearish Percentage of Shares Shorted3.65% of the float of Health Catalyst has been sold short.Short Interest Ratio / Days to CoverHealth Catalyst has a short interest ratio ("days to cover") of 5.2.Change versus previous monthShort interest in Health Catalyst has recently increased by 9.07%, indicating that investor sentiment is decreasing significantly. Dividend0.0 / 5Dividend StrengthN/A Dividend YieldHealth Catalyst does not currently pay a dividend.Dividend GrowthHealth Catalyst does not have a long track record of dividend growth. News and Social Media3.1 / 5News Sentiment0.89 News SentimentHealth Catalyst has a news sentiment score of 0.89. This score is calculated as an average of sentiment of articles about the company over the last seven days and ranges from 2 (good news) to -2 (bad news). This is a higher news sentiment than the 0.68 average news sentiment score of Healthcare companies.News Coverage This WeekMarketBeat has tracked 2 news articles for Health Catalyst this week, compared to 3 articles on an average week.Search Interest2 people have searched for HCAT on MarketBeat in the last 30 days. This is an increase of 100% compared to the previous 30 days. Company Ownership4.3 / 5Insider TradingAcquiring Shares Net Insider BuyingOver the last three months, insiders have purchased a net $105,610.00 in company stock, which represents 0.0791% of the company's market cap.Insider Buying vs. Insider SellingIn the past three months, Health Catalyst insiders have bought more of their company's stock than they have sold. Specifically, they have bought $105,610.00 in company stock and sold $0.00 in company stock.Percentage Held by Insiders19.40% of the stock of Health Catalyst is held by insiders. A high percentage of insider ownership can be a sign of company health.Percentage Held by Institutions85.00% of the stock of Health Catalyst is held by institutions. High institutional ownership can be a signal of strong market trust in this company.Read more about Health Catalyst's insider trading history. Receive HCAT Stock News and Ratings via Email Sign-up to receive the latest news and ratings for Health Catalyst and its competitors with MarketBeat's FREE daily newsletter. Submit View SMS TermsSMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy. HCAT Stock News HeadlinesAnalyzing Health Catalyst (NASDAQ:HCAT) & GoodRx (NASDAQ:GDRX)October 7, 2026 | americanbankingnews.comHealth Catalyst, Inc. (NASDAQ:HCAT) Stock Has Average Target Price of $2.45 According to BrokeragesOctober 1, 2026 | americanbankingnews.comGold did this exact thing in 1975… [then exploded]In 1975 the Fed raised rates and gold fell 50 percent. Headlines called the gold bull market dead. Instead gold climbed from 100 dollars in 1976 to 850 dollars by 1980, a 750 percent gain in under five years. Today the new Fed chair has floated another rate hike, and investors are reacting the same way they did in 1975. Analyst Garrett Goggin, CFA, CMT, founder of Golden Portfolio, says the setup rhymes with that era.October 12 at 1:00 AM | Golden Portfolio (Ad)Health Catalyst (HCAT): Buy, sell, or hold post Q2 earnings?September 30, 2026 | msn.comHealth Catalyst (HCAT) Stock Fair Value Falls As Analysts Cut Targets On Growth RisksSeptember 19, 2026 | finance.yahoo.comHealth Catalyst (NASDAQ:HCAT) CEO Acquires 59,000 SharesSeptember 17, 2026 | insidertrades.comHealth Catalyst Grants 2.7 Million RSUs to New CEO Simeon Kohl and Discloses Open Market Share PurchasesSeptember 14, 2026 | quiverquant.comQHealth Catalyst Reports Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)September 14, 2026 | globenewswire.comSee More Headlines HCAT Stock Analysis - Frequently Asked Questions How have HCAT shares performed this year? Health Catalyst's stock was trading at $2.39 at the beginning of the year. Since then, HCAT stock has decreased by 25.7% and is now trading at $1.7750. How were Health Catalyst's earnings last quarter? Health Catalyst, Inc. (NASDAQ:HCAT) issued its quarterly earnings data on Thursday, August, 6th. The company reported $0.04 EPS for the quarter, beating the consensus estimate of $0.03 by $0.01. The firm earned $70.49 million during the quarter, compared to analysts' expectations of $69.09 million. Health Catalyst had a negative trailing twelve-month return on equity of 1.83% and a negative net margin of 90.61%. Read the conference call transcript. When did Health Catalyst IPO? Health Catalyst (HCAT) raised $172 million in an IPO on Wednesday, July 24th 2019. The company issued 7,000,000 shares at $24.00-$25.00 per share. Goldman Sachs, J.P. Morgan and William Blair acted as the underwriters for the IPO and Piper Jaffray, Evercore ISI, SVB Leerink and SunTrust Robinson Humphrey were co-managers. How do I buy shares of Health Catalyst? Shares of HCAT stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services. What other stocks do shareholders of Health Catalyst own? Based on aggregate information from My MarketBeat watchlists, some other companies that Health Catalyst investors own include American Water Works (AWK), Humana (HUM), Waste Connections (WCN), The RMR Group (RMR), AUO (AUOTY), Voyager Therapeutics (VYGR) and DiamondRock Hospitality (DRH). Company Calendar Last Earnings8/06/2026Today10/12/2026Next Earnings (Estimated)11/09/2026Fiscal Year End12/31/2026Get Stock Alerts Health Indicator TradeSmith's Health IndicatorA long-term volatility-based measure designed for securities held 12 months or longer.Green: Strong and healthy uptrend with normal pullbacks.Yellow: Significant pullback but still within expected volatility.Red: Dropped beyond expected volatility; considered unhealthy. Green Zone (1m+) 1-Year History Oct 25 Jan 26 Apr 26 Jul 26 Oct 26 HCAT's financial health is in the Green zone, according to TradeSmith. HCAT has been in this zone for over one month. Industry, Sector and Symbol Stock ExchangeNASDAQ SectorHealthcare Industry Healthcare Technology Sub-IndustryHealthcare Technology Current SymbolNASDAQ:HCAT CIK1636422 Webwww.healthcatalyst.com Phone(801) 708-6800FaxN/AEmployees1,200Year Founded2008Price Target and Rating Average Price Target for Health Catalyst$2.15 High Price Target$3.00 Low Price Target$1.50 Potential Upside/Downside+21.8%Consensus RatingHold Rating Score (0-4)2.11 Research Coverage9 Analysts Profitability EPS (Trailing Twelve Months)($3.68) Trailing P/E RatioN/A Forward P/E RatioN/A P/E GrowthN/ANet Income-$177.97 million Net Margins-90.61% Pretax Margin-90.22% Return on Equity-1.83% Return on Assets-0.80% Debt Debt-to-Equity Ratio1.51 Current Ratio2.70 Quick Ratio2.70 Sales & Book Value Annual Sales$292.25 million Price / Sales0.45 Cash Flow$2.13 per share Price / Cash Flow0.83 Book Value$3.47 per share Price / Book0.51Miscellaneous Outstanding Shares75,256,000Free Float60,656,000Market Cap$132.83 million OptionableOptionable Beta1.54 Social Links The Best Nuclear Energy Stocks to BuyNuclear energy is entering a new growth cycle as rising power demand, expanding data centers, and renewed policy support bring the sector back into focus. After strong gains in recent years, the most impactful phase of nuclear investment may still be ahead. This report highlights seven nuclear energy stocks positioned across the value chain—combining near-term revenue with long-term upside as next-generation technologies scale. Click the link below to unlock the full list.Get This Free Report This page (NASDAQ:HCAT) was last updated on 10/12/2026 by MarketBeat.com Staff. From Our PartnersUrgent Attention to Executive Order #14363 (Buy This Stock Before Oct. 20thMarc Chaikin, a 60-year Wall Street veteran whose past clients include George Soros and Steve Cohen, built a s...Chaikin Analytics | SponsoredTrump To Relaunch USD?President Trump's summit with Xi Jinping drew headlines for tariffs and trade truces, but the real story may b...Porter & Company | SponsoredWhy major institutions are piling into this digital asset nowBlackRock, JPMorgan, Goldman Sachs, and Fidelity are reportedly accumulating a scarce blockchain asset - one t...Awesomely | SponsoredFree Ticker: Anthropic's silent partner could soar after record $2 trillion IPOAnthropic's IPO prospectus just leaked, revealing 261 pages tied to a record $2 trillion valuation. Beyond ...Monument Traders Alliance | SponsoredUrgent: Invest In ‘Elon’s iPhone’ Before July 22ndEarly Apple investors saw peak gains as high as 7,537% after the iPhone launched. Now, multiple insider source...StocksToTrade | SponsoredFederal Reserve Reveals Disturbing New Plan To Control Your MoneyA Federal Reserve filing, Docket No. OP-1670, is drawing scrutiny for language that could expand the Fed's vis...Weiss Ratings | SponsoredTomorrow, Wall Street goes home for two daysTomorrow at 4 PM Eastern, Wall Street closes for the weekend. Fund managers and billion-dollar accounts leave,...Tim Sykes | SponsoredThis high yielding “gold annuity” is starting to move…Garrett Goggin, a 20+ year gold analyst, has called major moves before: Montage Gold up 2,567%, G2 Goldfields ...Golden Portfolio | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Health Catalyst, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Health Catalyst With A Colleague Link copied to clipboard. Unlock superior investment research and tools. Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools and reports. Get MarketBeat All Access MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In Email Me a Login Link or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
